Skip to the content
Search
Beyond Type 2
Menu
BEYOND TYPE 2
Show sub menu
About
Our Story
Founding Partners
Board of Directors
Leadership Council
The Team
Join Us
Contact
Diabetes
Type 1 Info
Type 2 Info
Prediabetes Info
Forms of Diabetes
Newly Diagnosed
Diabetes Management
Pregnancy and Diabetes
Resources
GetInsulin.org
Insulin for T2D
Diabetes Management
Understanding T2D
Exercise
Food
Heart Health
Mental Health
Continuous Glucose Monitoring (CGM)
Veterans with Diabetes
Beyond Type 2 Advocacy
Stories
Diabetes News
Type 2 Stories
Community
En Español
Search
Tag:
mounjaro
Year in Review: The Biggest News in Diabetes Clinical Science
Highlights from the last year of diabetes research and treatment include new biosimilar insulins and updated screening and diagnosis guidelines.
Mounjaro: Its Powerful Potential to Treat Type 2 Diabetes + Obesity
Experts discuss the impressive impact and future potential of using Mounjaro (tirzepatide) to treat obesity and type 2 diabetes.
All About Mounjaro: A New Medication for Type 2 Diabetes
This new drug for type 2 diabetes and obesity is a once-weekly injection that may help you reach your A1c and weight loss goals and decrease insulin resistance.
FDA Approves Lilly’s Mounjaro: First of its Kind Medication for Treatment of Type 2 Diabetes
The FDA approved Mounjaro from Lilly, the first GIP/ GLP-1 receptor agonist to treat people with type 2 diabetes.
Beyond Type 2Beyond Type 2
